Caspase-3, caspase-8, and caspase-9 are also activated by KD5170, which is a mercaptoketone-based histone deacetylase inhibitor that has shown a high antiproliferative efficacy in MM cell lines. Here, CASP9 is linked to Miyoshi myopathy.